Aster DM Healthcare has announced key strategic developments aimed at expanding its footprint in India. In a meeting held on July 30, 2025, the company’s Investment and Finance Committee approved two major decisions: increasing its stake in a key subsidiary and signing a lease for a new super-specialty hospital in Bengaluru.
The company will acquire an additional 13% equity in Dr. Ramesh Cardiac & Multispecialty Hospital Pvt Ltd (DRCM), increasing its total shareholding from 57.49% to 70.49%. This INR 63.01 crore cash deal comes as part of a put option exercised by DRCM’s promoters under the 2016 shareholders agreement. DRCM, based in Andhra Pradesh, reported a turnover of ₹258 crore in FY25.
In a parallel move, Aster has entered into a lease agreement with KEMWELL Private Limited for a composite property in Yeshwanthpur, Bengaluru. The company plans to set up a 500-bed super-specialty hospital on the site, with operations expected to begin in H2 FY28-29. This ₹580 crore investment will be funded through internal accruals and bank loans. The new hospital will serve the fast-growing northwest Bengaluru corridor, offering advanced tertiary care with excellent metro and rail connectivity.
These initiatives reflect Aster’s continued focus on expanding its healthcare network across India and strengthening its position in the high-growth southern market.
